在治疗HER2阳性转移性乳腺癌的更新
Alzira R M Avelino1, Soumya Pulipati1, Kevin Jamouss2
1Division of Hematology-Oncology, University of Massachusetts Chan Medical School - Baystate, Springfield, MA, USA.
Current treatment options in oncology
|November 9, 2024
概括
对HER2阳性转移性乳腺癌的治疗选择有了显著的进步. 抗体药物联合体,如trastuzumab deruxte,可以改善无进展生存率,推动新的临床试验调查.
科学领域:
- 在瘤学瘤学.
- 医学科学 医学科学 医学科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在过去的20年里,对HER2阳性转移性乳腺癌的治疗迅速发展.
- 一个单克隆抗体的trastuzumab是最初的突破性疗法.
- 目前的第一线治疗通常涉及双重HER2阻断与分类剂化疗.
研究的目的:
- 审查 HER2 阳性转移性乳腺癌不断变化的治疗环境.
- 突出最近的进展,包括抗体-药物合物和新的治疗点.
- 讨论管理这种疾病的未来方向和临床问题.
主要方法:
- 审查最近的临床试验数据和治疗进展.
- 对治疗结果的分析,特别是无进展生存率.
- 讨论新出现的目标和结合策略.
主要成果:
- 抗体-药物合物,如trastuzumab deruxtecan,已经证明了优越的无进展生存率.
- 临床试验正在探索抗体-药物合体在一线设置.
- 研究目标包括PI3KCA突变,PD-L1和CDK4/6,其中诸如图卡提尼布,卡佩西塔和特拉斯图祖马布等组合显示出有前途.
结论:
- 对HER2阳性转移性乳腺癌的治疗选择已经大大扩大.
- 目前正在进行的研究重点是优化治疗序列,降级策略和管理大脑转移.
- 尽管它具有侵略性,但患者的治疗结果仍在不断改善,使用新型疗法.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
13:19Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
Published on: April 26, 2024
2.5K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Vaccines
340
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
340
